nAMD patients may benefit from anti-VEGF combination therapy.

Published Date: 09 Jun 2023

OPT-302, a biologic inhibitor of VEGF-C and VEGF-D, was combined with ranibizumab in studies to assess its therapeutic effectiveness and safety.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Radioactive ion beams successfully treat animal tumors in study

2.

A computer-aided diagnostic system for improved detection of breast cancer.

3.

Ultrasound bras; HPV and thyroid cancer; language minimizing adverse events.

4.

Study reveals that older women frequently receive an incorrect breast cancer diagnosis.

5.

Durvalumab Plus BCG Earns FDA Nod for Bladder Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot